Acute Lymphoblastic Leukemia

Showing NaN - NaN of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • TC-110 T Cells
  • +2 more
  • Denver, Colorado
  • +2 more
Jun 25, 2020

Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • BP1001
  • BP1001 in combination with LDAC
  • Houston, Texas
    M. D. Anderson Cancer Center
May 26, 2020

Acute Lymphoblastic Leukemia Trial in United States (JCAR015 (CD19-targeted CAR T cells))

Terminated
  • Acute Lymphoblastic Leukemia
  • JCAR015 (CD19-targeted CAR T cells)
  • Birmingham, Alabama
  • +17 more
Apr 30, 2020

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Tetanus
  • Houston, Texas
  • +1 more
Apr 20, 2020

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Birmingham, Alabama
  • +133 more
Apr 4, 2020

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)

Terminated
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Atlanta, Georgia
  • +10 more
Feb 12, 2020

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Acute Lymphoblastic Leukemia Trial in Atlanta, Chicago, Houston (Vincristine Sulfate Liposomes Injection, Dexamethasone)

Completed
  • Acute Lymphoblastic Leukemia
  • Atlanta, Georgia
  • +2 more
Dec 10, 2019

Acute Lymphoblastic Leukemia Trial in Houston (CMC-544 (Inotuzumab Ozogamycin), Rituximab)

Completed
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 21, 2019

Acute Lymphoblastic Leukemia Trial in Worldwide (inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high

Completed
  • Acute Lymphoblastic Leukemia
  • inotuzumab ozogamicin
  • +3 more
  • La Jolla, California
  • +197 more
Dec 20, 2018

Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation Trial in Houston (Busulfan, Clofarabine, Thymoglobulin)

Completed
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 11, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Acute Lymphoblastic Leukemia Trial in Columbus, Memphis, Houston (MOR00208 (formerly Xmab5574))

Terminated
  • Acute Lymphoblastic Leukemia
  • MOR00208 (formerly Xmab5574)
  • Columbus, Ohio
  • +2 more
Feb 20, 2018

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Nov 16, 2017

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)

Completed
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Duarte, California
  • +38 more
Jul 18, 2017

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (pegcrisantaspase)

Terminated
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Phoenix, Arizona
  • +42 more
Mar 6, 2017

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)

Completed
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Aurora, Colorado
  • +29 more
Dec 16, 2016

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 16, 2016